SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-030179
Filing Date
2022-05-27
Accepted
2022-05-27 17:22:19
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_allaritythera.htm   iXBRL 10-Q 786730
2 CERTIFICATION f10q0322ex31-1_allarity.htm EX-31.1 11255
3 CERTIFICATION f10q0322ex31-2_allarity.htm EX-31.2 10983
4 CERTIFICATION f10q0322ex32-1_allarity.htm EX-32.1 4406
5 CERTIFICATION f10q0322ex32-2_allarity.htm EX-32.2 4276
  Complete submission text file 0001213900-22-030179.txt   5349309

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20220331.xsd EX-101.SCH 73826
7 XBRL CALCULATION FILE allr-20220331_cal.xml EX-101.CAL 36954
8 XBRL DEFINITION FILE allr-20220331_def.xml EX-101.DEF 263379
9 XBRL LABEL FILE allr-20220331_lab.xml EX-101.LAB 528423
10 XBRL PRESENTATION FILE allr-20220331_pre.xml EX-101.PRE 280623
86 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_allaritythera_htm.xml XML 687655
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 22979038
SIC: 2834 Pharmaceutical Preparations